Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / hepion ends phase 2 study for nash drug due to cash

IVA - Hepion ends Phase 2 study for NASH drug due to cash restraints

Inventiva S.A.

2024-04-19 17:10:14 ET

More on ContraVir

For further details see:

Hepion ends Phase 2 study for NASH drug due to cash restraints
Stock Information
Company Name: Inventiva S.A.
Stock Symbol: IVA
Market: NASDAQ
Website: inventivapharma.com
Menu
IVA IVA Quote IVA Short IVA News IVA Articles IVA Message Board
Get IVA Alerts

News, Short Squeeze, Breakout and More Instantly...